HIV 1 News and Research

RSS

Early 2022 monkeypox virus spread among sexual networks of bisexual and gay males in England

Researchers investigated the cause of the early monkeypox virus transmission across bisexual and gay men's sexual networks in England in 2022.

16 Aug 2022

Portable diagnostic device deployed in sub-Saharan Africa to identify cases of Kaposi sarcoma

A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine has been deployed in clinical tests in Uganda to identify cases of Kaposi sarcoma, a common yet difficult-to-detect cancer that often signals the presence of HIV infection.

11 Aug 2022

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

Researchers investigated the susceptibility of naturally-occurring severe acute respiratory syndrome coronavirus 2 main protease variants to protease inhibitor drugs, including nirmatrelvir and ensitrelvir.

11 Aug 2022

UIC focuses on developing an antiviral therapy for filoviruses

Researchers at the University of Illinois Chicago are working with the National Institutes of Health and researchers from across the country to establish a center for antiviral drug development for pandemic-level viruses, including Ebola and SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2022

Transposable element controls the immune system to favor host survival during virus infection

Researchers from UNSW Sydney have discovered that a particular transposable element, or jumping gene, in the genome has a profound effect on the immune response to virus infection.

11 Aug 2022

Researchers describe case report of male monkeypox patient

In a new case study, researchers described the case of a male patient with monkeypox.

10 Aug 2022

IRB scientists identify critical spots on the genome where gene editing could cause an unwanted response

CRISPR/Cas9 is a commonly used, very precise, gene editing technique whose development, by Jennifer A. Doudna and Emmanuelle Charpentier, was recognised with the 2020 Nobel Prize in Chemistry. Commonly known as "genetic scissors", CRISPR allows the introduction of the desired DNA sequence into (virtually) any spot of the genome, thus modifying or inactivating a gene. This technique is widely used in biomedical research and some CRISPR-based therapies are in clinical trials for the treatment of human blood disorders, some types of cancer and HIV, among other conditions.

10 Aug 2022

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

Just as with COVID-19, future viral outbreaks will have plenty of time to spread before a vaccine becomes available. A new approach developed at NTNU can save lives and prevent the need to shut down society.

9 Aug 2022

New CDC Vital Signs report: Less than a third of people diagnosed with hepatitis C get timely treatment

Hepatitis C can cause advanced liver disease, liver cancer, and death and affects millions in the United States.

9 Aug 2022

How effective is tecovirimat as a treatment against monkeypox?

A new study evaluated the use of tecovirimat for monkeypox treatment during the current outbreak.

9 Aug 2022

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Scientists explored the influence of SARS-CoV-2 extended gap vaccination on the variants of concern neutralization.

9 Aug 2022

Combination of interventions more effective at reducing children’s symptoms of depression and anxiety

Behavioral scientists have long researched how to help children cope with extreme adversity – such as poverty or exposure to violence. Yanping Jiang, a researcher at the Rutgers Institute for Health, thinks she's found the answer in rural China.

9 Aug 2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

A clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the medications, but the rates of behavior change for alcohol consumption and smoking were high in all treatment groups. Results suggest these medications could play an important role to reduce alcohol use and smoking at the same time. Unexpectedly, nicotine replacement therapy performed as well as the prescription drugs varenicline and cytisine.

8 Aug 2022

HIV 1 News and Research

Early 2022 monkeypox virus spread among sexual networks of bisexual and gay males in England

Portable diagnostic device deployed in sub-Saharan Africa to identify cases of Kaposi sarcoma

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

UIC focuses on developing an antiviral therapy for filoviruses

Transposable element controls the immune system to favor host survival during virus infection

Researchers describe case report of male monkeypox patient

IRB scientists identify critical spots on the genome where gene editing could cause an unwanted response

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

New CDC Vital Signs report: Less than a third of people diagnosed with hepatitis C get timely treatment

How effective is tecovirimat as a treatment against monkeypox?

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Combination of interventions more effective at reducing children’s symptoms of depression and anxiety

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

What does the future look like for TB care?

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

mRNA vaccines induce faster antibody response against infectious diseases

Symptoms of monkeypox differ from previous outbreaks

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News